1. Leukemia Pathogenesis & drug Resistance
a. Investigating molecular drivers of leukemia progression and drug resistance mechanisms (e.g., glucocorticoid resistance);
2. CAR-T Immunotherapy
a.Engineering novel CAR-T cell therapies against hematologic malignancies and solid tumors and translating preclinical findings into clinical trials.
b.Developing approaches to reverse T-cell exhaustion and enhance immunotherapy responsiveness.
1. Leukemia Pathogenesis & drug Resistance
a. Investigating molecular drivers of leukemia progression and drug resistance mechanisms (e.g., glucocorticoid resistance);
2. CAR-T Immunotherapy
a.Engineering novel CAR-T cell therapies against hematologic malignancies and solid tumors and translating preclinical findings into clinical trials.
b.Developing approaches to reverse T-cell exhaustion and enhance immunotherapy responsiveness.